{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:36:06Z","timestamp":1788194166362,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1078399"],"award-info":[{"award-number":["GNT1078399"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1177194"],"award-info":[{"award-number":["GNT1177194"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Endometriosis is a common, gynaecological disease characterised by the presence of endometrial-like cells growing outside the uterus. Lesions appear at multiple locations, present with variation in appearance, size and depth of invasion. Despite hormones being the recommended first-line treatment, their efficacy, success and side effects vary widely amongst study populations. Current, hormonal medication for endometriosis is designed to suppress systemic oestrogen. Whether these hormones can influence the lesions themselves is not yet clear. Evidence of hormone receptor expression in endometriotic lesions and their ability to respond is conflicting. A variation in their expression, activation of transcriptional co-regulators and the potential to respond may contribute to their variation in patient outcomes. Identifying patients who would benefit from hormonal treatments remain an important goal in endometriosis research.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Using gene expression data from endometriosis lesions including endometrioma (OMA, <jats:italic>n<\/jats:italic>\u2009=\u200928), superficial peritoneal lesions (SUP, <jats:italic>n<\/jats:italic>\u2009=\u200972) and deeply infiltrating lesions (DIE, <jats:italic>n<\/jats:italic>\u2009=\u200978), we performed principal component analysis, differential gene expression and gene correlation analyses to assess the impact of menstrual stage, lesion subtype and hormonal treatment on the gene expression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The gene expression profiles did not vary based on menstrual stage, but could distinguish lesion subtypes with OMA significantly differentiating from both SUP and DIE. Additionally, the effect of oestrogen suppression medication altered the gene expression profile in OMA, while such effect was not observed in SUP or DIE. Analysis of the target receptors for hormonal medication indicated <jats:italic>ESR2<\/jats:italic> was differentially expressed in OMA and that genes that correlated with <jats:italic>ESR2<\/jats:italic> varied significantly between medicated and non-medicated OMA samples.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our results demonstrate of the different lesion types OMA present with strongest response to hormonal treatment directly through <jats:italic>ESR2<\/jats:italic>. The data suggests that there may be the potential to target treatment options to individual patients based on pre-surgical diagnoses.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-023-03166-1","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T10:02:41Z","timestamp":1700733761000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Gene expression profiles separate endometriosis lesion subtypes and indicate a sensitivity of endometrioma to estrogen suppressive treatments through elevated ESR2 expression"],"prefix":"10.1186","volume":"21","author":[{"given":"Sushma","family":"Marla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Mortlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taija","family":"Heinosalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Poutanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant W.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett David","family":"McKinnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,23]]},"reference":[{"issue":"5","key":"3166_CR1","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1080\/13625187.2017.1374362","volume":"22","author":"L Cea Soriano","year":"2017","unstructured":"Cea Soriano L, L\u00f3pez-Garcia E, Schulze-Rath R, Garcia Rodr\u00edguez LA. Incidence, treatment and recurrence of endometriosis in a UK-based population analysis using data from The Health Improvement Network and the Hospital Episode Statistics database. Eur J Contracept Reprod Health Care. 2017;22(5):334\u201343.","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"4","key":"3166_CR2","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/humupd\/dmp007","volume":"15","author":"SW Guo","year":"2009","unstructured":"Guo SW. Recurrence of endometriosis and its control. Hum Reprod Update. 2009;15(4):441\u201361.","journal-title":"Hum Reprod Update"},{"issue":"3","key":"3166_CR3","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.fertnstert.2015.01.006","volume":"103","author":"AM Quaas","year":"2015","unstructured":"Quaas AM, Weedin EA, Hansen KR. On-label and off-label drug use in the treatment of endometriosis. Fertil Steril. 2015;103(3):612\u201325.","journal-title":"Fertil Steril"},{"issue":"4","key":"3166_CR4","doi-asserted-by":"publisher","first-page":"hoab025","DOI":"10.1093\/hropen\/hoab025","volume":"2021","author":"N Vermeulen","year":"2021","unstructured":"International working group of AAGL E, ESHRE, WES, Vermeulen N, Abrao MS, Einarsson JI, Horne AW, Johnson NP, Lee TTM, Missmer S, Petrozza J, et al. Endometriosis classification, staging and reporting systems: a review on the road to a universally accepted endometriosis classification\u2020,\u2021. Hum Reprod Open. 2021;2021(4):hoab025.","journal-title":"Hum Reprod Open"},{"issue":"2","key":"3166_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.fertnstert.2008.06.003","volume":"92","author":"C Chapron","year":"2009","unstructured":"Chapron C, Pietin-Vialle C, Borghese B, Davy C, Foulot H, Chopin N. Associated ovarian endometrioma is a marker for greater severity of deeply infiltrating endometriosis. Fertil Steril. 2009;92(2):453\u20137.","journal-title":"Fertil Steril"},{"issue":"2","key":"3166_CR6","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3390\/jcm9020496","volume":"9","author":"K Nirgianakis","year":"2020","unstructured":"Nirgianakis K, Ma L, McKinnon B, Mueller MD. Recurrence patterns after surgery in patients with different endometriosis subtypes: a long-term hospital-based cohort study. J Clin Med. 2020;9(2):496.","journal-title":"J Clin Med"},{"issue":"5","key":"3166_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1089\/omi.2009.0027","volume":"13","author":"J Hiissa","year":"2009","unstructured":"Hiissa J, Elo LL, Huhtinen K, Perheentupa A, Poutanen M, Aittokallio T. Resampling reveals sample-level differential expression in clinical genome-wide studies. OMICS. 2009;13(5):381\u201396.","journal-title":"OMICS"},{"issue":"10","key":"3166_CR8","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s40265-018-0928-0","volume":"78","author":"S Ferrero","year":"2018","unstructured":"Ferrero S, Barra F, Maggiore ULR. Current and emerging therapeutics for the management of endometriosis. Drugs. 2018;78(10):995\u20131012.","journal-title":"Drugs"},{"issue":"3","key":"3166_CR9","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/humrep\/det457","volume":"29","author":"GA Dunselman","year":"2014","unstructured":"Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D\u2019Hooghe T, De Bie B, Heikinheimo O, Horne AW, Kiesel L, Nap A, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29(3):400\u201312.","journal-title":"Hum Reprod"},{"issue":"1","key":"3166_CR10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/humupd\/dmaa033","volume":"27","author":"A Zakhari","year":"2021","unstructured":"Zakhari A, Delpero E, McKeown S, Tomlinson G, Bougie O, Murji A. Endometriosis recurrence following post-operative hormonal suppression: a systematic review and meta-analysis. Hum Reprod Update. 2021;27(1):96\u2013107.","journal-title":"Hum Reprod Update"},{"issue":"3","key":"3166_CR11","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/humrep\/det457","volume":"29","author":"GAJ Dunselman","year":"2014","unstructured":"Dunselman GAJ, Vermeulen N, Becker C, Calhaz-Jorge C, D\u2019Hooghe T, De Bie B, Heikinheimo O, Horne AW, Kiesel L, Nap A, et al. ESHRE guideline: management of women with endometriosis \u2020. Hum Reprod. 2014;29(3):400\u201312.","journal-title":"Hum Reprod"},{"issue":"8","key":"3166_CR12","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.3390\/ijms21082815","volume":"21","author":"E Chantalat","year":"2020","unstructured":"Chantalat E, Valera MC, Vaysse C, Noirrit E, Rusidze M, Weyl A, Vergriete K, Buscail E, Lluel P, Fontaine C, et al. Estrogen receptors and endometriosis. Int J Mol Sci. 2020;21(8):2815.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"3166_CR13","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/PAI.0000000000000663","volume":"27","author":"M Col\u00f3n-Caraballo","year":"2019","unstructured":"Col\u00f3n-Caraballo M, Garc\u00eda M, Mendoza A, Flores I. Human endometriosis tissue microarray reveals site-specific expression of estrogen receptors, progesterone receptor, and Ki67. Appl Immunohistochem Mol Morphol. 2019;27(7):491\u2013500.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"3166_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jri.2016.06.004","volume":"117","author":"G Grandi","year":"2016","unstructured":"Grandi G, Mueller MD, Papadia A, Kocbek V, Bersinger NA, Petraglia F, Cagnacci A, McKinnon B. Inflammation influences steroid hormone receptors targeted by progestins in endometrial stromal cells from women with endometriosis. J Reprod Immunol. 2016;117:30\u20138.","journal-title":"J Reprod Immunol"},{"issue":"4","key":"3166_CR15","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/aji.12552","volume":"76","author":"G Grandi","year":"2016","unstructured":"Grandi G, Mueller M, Bersinger N, Papadia A, Nirgianakis K, Cagnacci A, McKinnon B. Progestin suppressed inflammation and cell viability of tumor necrosis factor-alpha-stimulated endometriotic stromal cells. Am J Reprod Immunol. 2016;76(4):292\u20138.","journal-title":"Am J Reprod Immunol"},{"key":"3166_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/751571","volume":"2015","author":"G Grandi","year":"2015","unstructured":"Grandi G, Toss A, Cortesi L, Botticelli L, Volpe A, Cagnacci A. The association between endometriomas and ovarian cancer: preventive effect of inhibiting ovulation and menstruation during reproductive life. Biomed Res Int. 2015;2015: 751571.","journal-title":"Biomed Res Int"},{"issue":"12","key":"3166_CR17","doi-asserted-by":"publisher","first-page":"4561","DOI":"10.1210\/jc.2018-01227","volume":"103","author":"VA Flores","year":"2018","unstructured":"Flores VA, Vanhie A, Dang T, Taylor HS. Progesterone receptor status predicts response to progestin therapy in endometriosis. J Clin Endocrinol Metab. 2018;103(12):4561\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3166_CR18","doi-asserted-by":"publisher","first-page":"11424","DOI":"10.1038\/s41598-018-29462-y","volume":"8","author":"JN Fung","year":"2018","unstructured":"Fung JN, Mortlock S, Girling JE, Holdsworth-Carson SJ, Teh WT, Zhu Z, Lukowski SW, McKinnon BD, McRae A, Yang J, et al. Genetic regulation of disease risk and endometrial gene expression highlights potential target genes for endometriosis and polycystic ovarian syndrome. Sci Rep. 2018;8(1):11424.","journal-title":"Sci Rep"},{"issue":"1","key":"3166_CR19","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41597-020-00623-x","volume":"7","author":"M Gabriel","year":"2020","unstructured":"Gabriel M, Fey V, Heinosalo T, Adhikari P, Rytk\u00f6nen K, Komulainen T, Huhtinen K, Laajala TD, Siitari H, Virkki A, et al. A relational database to identify differentially expressed genes in the endometrium and endometriosis lesions. Sci Data. 2020;7(1):284.","journal-title":"Sci Data"},{"key":"3166_CR20","unstructured":"Gabriel M, Poutanen M: Transcriptome analysis of differential gene expression of endometrium, peritoneum and endometriosis lesions. Gene Expression Omnibus. 2019. https:\/\/identifiers.org\/geo:GSE141549"},{"issue":"4","key":"3166_CR21","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/00006254-195008000-00044","volume":"5","author":"RW Noyes","year":"1950","unstructured":"Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Obstet Gynecol Surv. 1950;5(4):561\u20134.","journal-title":"Obstet Gynecol Surv"},{"issue":"2","key":"3166_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/humrep\/dez279","volume":"35","author":"S Mortlock","year":"2020","unstructured":"Mortlock S, Kendarsari RI, Fung JN, Gibson G, Yang F, Restuadi R, Girling JE, Holdsworth-Carson SJ, Teh WT, Lukowski SW, et al. Tissue specific regulation of transcription in endometrium and association with disease. Human reproduction (Oxford, England). 2020;35(2):377\u201393.","journal-title":"Human reproduction (Oxford, England)"},{"key":"3166_CR23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/978-1-0716-0327-7_19","volume-title":"Bioinformatics for Cancer Immunotherapy: Methods and Protocols","author":"D Aran","year":"2020","unstructured":"Aran D. Cell-type enrichment analysis of bulk transcriptomes using xCell. In: Boegel S, editor. Bioinformatics for Cancer Immunotherapy: Methods and Protocols. New York: Springer US; 2020. p. 263\u201376."},{"issue":"5","key":"3166_CR24","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"5","key":"3166_CR25","doi-asserted-by":"publisher","first-page":"489","DOI":"10.2217\/14622416.9.5.489","volume":"9","author":"W Zhang","year":"2008","unstructured":"Zhang W, Dolan ME. Ancestry-related differences in gene expression: findings may enhance understanding of health disparities between populations. Pharmacogenomics. 2008;9(5):489\u201392.","journal-title":"Pharmacogenomics"},{"key":"3166_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/frph.2021.795464","volume":"3","author":"S Mortlock","year":"2021","unstructured":"Mortlock S, McKinnon B, Montgomery GW. Genetic regulation of transcription in the endometrium in health and disease. Front Reprod Health. 2021;3: 795464.","journal-title":"Front Reprod Health"},{"issue":"3","key":"3166_CR27","doi-asserted-by":"publisher","first-page":"R75","DOI":"10.1530\/JOE-20-0106","volume":"246","author":"DA Gibson","year":"2020","unstructured":"Gibson DA, Simitsidellis I, Collins F, Saunders PTK. Androgens, oestrogens and endometrium: a fine balance between perfection and pathology. J Endocrinol. 2020;246(3):R75\u201393.","journal-title":"J Endocrinol"},{"issue":"12","key":"3166_CR28","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1093\/humrep\/deaa249","volume":"35","author":"EM Colgrave","year":"2020","unstructured":"Colgrave EM, Bittinger S, Healey M, Dior UP, Rogers PAW, Keast JR, Girling JE, Holdsworth-Carson SJ. Superficial peritoneal endometriotic lesions are histologically diverse and rarely demonstrate menstrual cycle synchronicity with matched eutopic endometrium. Hum Reprod. 2020;35(12):2701\u201314.","journal-title":"Hum Reprod"},{"issue":"5","key":"3166_CR29","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2217\/pmt-2019-0010","volume":"9","author":"HS Taylor","year":"2019","unstructured":"Taylor HS, Dun EC, Chwalisz K. Clinical evaluation of the oral gonadotropin-releasing hormone-antagonist elagolix for the management of endometriosis-associated pain. Pain Manag. 2019;9(5):497\u2013515.","journal-title":"Pain Manag"},{"issue":"5","key":"3166_CR30","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1093\/humrep\/dey026","volume":"33","author":"T Heinosalo","year":"2018","unstructured":"Heinosalo T, Gabriel M, Kallio L, Adhikari P, Huhtinen K, Laajala TD, Kaikkonen E, Mehmood A, Suvitie P, Kujari H, et al. Secreted frizzled-related protein 2 (SFRP2) expression promotes lesion proliferation via canonical WNT signaling and indicates lesion borders in extraovarian endometriosis. Hum Reprod. 2018;33(5):817\u201331.","journal-title":"Hum Reprod"},{"issue":"11","key":"3166_CR31","doi-asserted-by":"publisher","first-page":"4228","DOI":"10.1210\/jc.2012-1154","volume":"97","author":"K Huhtinen","year":"2012","unstructured":"Huhtinen K, Desai R, St\u00e5hle M, Salminen A, Handelsman DJ, Perheentupa A, Poutanen M. Endometrial and endometriotic concentrations of estrone and estradiol are determined by local metabolism rather than circulating levels. J Clin Endocrinol Metab. 2012;97(11):4228\u201335.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"3166_CR32","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s11154-021-09666-w","volume":"23","author":"S Vannuccini","year":"2022","unstructured":"Vannuccini S, Clemenza S, Rossi M, Petraglia F. Hormonal treatments for endometriosis: the endocrine background. Rev Endocr Metab Disord. 2022;23(3):333\u201355.","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"3166_CR33","first-page":"90","volume":"46","author":"M Vignali","year":"2021","unstructured":"Vignali M, Pisoni S, Gentilini D, Spada E, Solima E, Vigan\u00f2 P, Candiani M, Busacca M. AM DIB: Hormonal therapy potentiates the effect of surgery on gene expression profile of peripheral blood mononuclear cells in patients affected by endometriosis. Minerva Endocrinol (Torino). 2021;46(1):90\u20138.","journal-title":"Minerva Endocrinol (Torino)"},{"issue":"4","key":"3166_CR34","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/humupd\/dmz005","volume":"25","author":"BD Yilmaz","year":"2019","unstructured":"Yilmaz BD, Bulun SE. Endometriosis and nuclear receptors. Hum Reprod Update. 2019;25(4):473\u201385.","journal-title":"Hum Reprod Update"},{"issue":"1\u20132","key":"3166_CR35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.mce.2004.02.020","volume":"221","author":"PR Lindgren","year":"2004","unstructured":"Lindgren PR, Cajander S, B\u00e4ckstr\u00f6m T, Gustafsson JA, M\u00e4kel\u00e4 S, Olofsson JI. Estrogen and progesterone receptors in ovarian epithelial tumors. Mol Cell Endocrinol. 2004;221(1\u20132):97\u2013104.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"3166_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1067\/mob.2003.328","volume":"189","author":"AJ Li","year":"2003","unstructured":"Li AJ, Baldwin RL, Karlan BY. Estrogen and progesterone receptor subtype expression in normal and malignant ovarian epithelial cell cultures. Am J Obstet Gynecol. 2003;189(1):22\u20137.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"3166_CR37","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/S0015-0282(01)01783-6","volume":"75","author":"S Matsuzaki","year":"2001","unstructured":"Matsuzaki S, Murakami T, Uehara S, Canis M, Sasano H, Okamura K. Expression of estrogen receptor alpha and beta in peritoneal and ovarian endometriosis. Fertil Steril. 2001;75(6):1198\u2013205.","journal-title":"Fertil Steril"},{"issue":"8","key":"3166_CR38","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1093\/molehr\/5.8.742","volume":"5","author":"J Fujimoto","year":"1999","unstructured":"Fujimoto J, Hirose R, Sakaguchi H, Tamaya T. Expression of oestrogen receptor-alpha and -beta in ovarian endometriomata. Mol Hum Reprod. 1999;5(8):742\u20137.","journal-title":"Mol Hum Reprod"},{"issue":"7","key":"3166_CR39","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/molehr\/5.7.651","volume":"5","author":"AW Brandenberger","year":"1999","unstructured":"Brandenberger AW, Lebovic DI, Tee MK, Ryan IP, Tseng JF, Jaffe RB, Taylor RN. Oestrogen receptor (ER)-alpha and ER-beta isoforms in normal endometrial and endometriosis-derived stromal cells. Mol Hum Reprod. 1999;5(7):651\u20135.","journal-title":"Mol Hum Reprod"},{"issue":"2","key":"3166_CR40","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1210\/jc.2008-1466","volume":"94","author":"E Trukhacheva","year":"2009","unstructured":"Trukhacheva E, Lin Z, Reierstad S, Cheng Y-H, Milad M, Bulun SE. Estrogen receptor (ER) \u03b2 regulates ER\u03b1 expression in stromal cells derived from ovarian endometriosis. J Clin Endocrinol Metab. 2009;94(2):615\u201322.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"3166_CR41","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1095\/biolreprod.107.061804","volume":"77","author":"Q Xue","year":"2007","unstructured":"Xue Q, Lin Z, Cheng YH, Huang CC, Marsh E, Yin P, Milad MP, Confino E, Reierstad S, Innes J, et al. Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis. Biol Reprod. 2007;77(4):681\u20137.","journal-title":"Biol Reprod"},{"issue":"8","key":"3166_CR42","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1210\/me.2013-1421","volume":"28","author":"D Monsivais","year":"2014","unstructured":"Monsivais D, Dyson MT, Yin P, Coon JS, Navarro A, Feng G, Malpani SS, Ono M, Ercan CM, Wei JJ, et al. ER\u03b2- and Prostaglandin E2-regulated pathways integrate cell proliferation via Ras-like and estrogen-regulated growth inhibitor in endometriosis. Mol Endocrinol. 2014;28(8):1304\u201315.","journal-title":"Mol Endocrinol"},{"issue":"4","key":"3166_CR43","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2015.10.034","volume":"163","author":"J Han Sang","year":"2015","unstructured":"Han Sang J, Jung Sung Y, Wu S-P, Hawkins Shannon M, Park Mi J, Kyo S, Qin J, Lydon John P, Tsai Sophia Y, Tsai M-J, et al. Estrogen receptor \u03b2 modulates apoptosis complexes and the inflammasome to drive the pathogenesis of endometriosis. Cell. 2015;163(4):960\u201374.","journal-title":"Cell"},{"issue":"4","key":"3166_CR44","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2015.10.034","volume":"163","author":"SJ Han","year":"2015","unstructured":"Han SJ, Jung SY, Wu SP, Hawkins SM, Park MJ, Kyo S, Qin J, Lydon JP, Tsai SY, Tsai MJ, et al. Estrogen receptor \u03b2 modulates apoptosis complexes and the inflammasome to drive the pathogenesis of endometriosis. Cell. 2015;163(4):960\u201374.","journal-title":"Cell"},{"issue":"8","key":"3166_CR45","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1016\/j.ajpath.2015.04.012","volume":"185","author":"E Greaves","year":"2015","unstructured":"Greaves E, Temp J, Esnal-Zufiurre A, Mechsner S, Horne AW, Saunders PT. Estradiol is a critical mediator of macrophage-nerve cross talk in peritoneal endometriosis. Am J Pathol. 2015;185(8):2286\u201397.","journal-title":"Am J Pathol"},{"issue":"271","key":"3166_CR46","doi-asserted-by":"publisher","first-page":"271ra279","DOI":"10.1126\/scitranslmed.3010626","volume":"7","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Gong P, Chen Y, Nwachukwu J, Srinivasan S, Ko C, Bagchi M, Taylor R, Korach K, Nettles K. Dual suppression of estrogenic and inflammatory activities for targeting of endometriosis. Sci Transl Med. 2015;7(271):271ra279.","journal-title":"Sci Transl Med"},{"issue":"3","key":"3166_CR47","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1530\/JOE-17-0700","volume":"237","author":"YJ Cho","year":"2018","unstructured":"Cho YJ, Lee JE, Park MJ, O\u2019Malley BW, Han SJ. Bufalin suppresses endometriosis progression by inducing pyroptosis and apoptosis. J Endocrinol. 2018;237(3):255\u201369.","journal-title":"J Endocrinol"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-03166-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-023-03166-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-03166-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T20:27:05Z","timestamp":1717100825000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-023-03166-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,23]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3166"],"URL":"https:\/\/doi.org\/10.1186\/s12916-023-03166-1","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,23]]},"assertion":[{"value":"1 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The project and data analysis was approved by the University of Queensland Human Research ethics committee (2016001723).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"460"}}